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Abstract
Background: Fasciola gigantica-induced immunomodulation is a major hurdle faced by the host for controlling
infection. Here, we elucidated the role of F. gigantica Ras-related protein Rab10 (FgRab10) in the modulation of key
functions of peripheral blood mononuclear cells (PBMCs) of goats.
Methods: We cloned and expressed recombinant FgRab10 (rFgRab10) protein and examined its effects on several
functions of goat PBMCs. Protein interactors of rFgRab10 were predicted in silico by querying the databases Intact,
String, BioPlex and BioGrid. In addition, a total energy analysis of each of the identified interactions was also conducted.
Gene Ontology (GO) enrichment analysis was carried out using FuncAssociate 3.0.
Results: The FgRab10 gene (618 bp), encodes 205-amino-acid residues with a molecular mass of ~23 kDa, had
complete nucleotide sequence homology with F. hepatica Ras family protein gene (PIS87503.1). The rFgRab10 protein
specifically cross-reacted with anti-Fasciola antibodies as shown by Western blot and immunofluorescence analysis. This
protein exhibited multiple effects on goat PBMCs, including increased production of cytokines [interleukin-2 (IL-2), IL-4,
IL-10, transforming growth factor beta (TGF-β) and interferon gamma (IFN-γ)] and total nitric oxide (NO), enhancing
apoptosis and migration of PBMCs, and promoting the phagocytic ability of monocytes. However, it significantly
inhibited cell proliferation. Homology modelling revealed 63% identity between rFgRab10 and human Rab10 protein
(Uniprot ID: P61026). Protein interaction network analysis revealed more stabilizing interactions between Rab proteins
geranylgeranyltransferase component A 1 (CHM) and Rab proteins geranylgeranyltransferase component A 2 (CHML)
and rFgRab10 protein. Gene Ontology analysis identified RabGTPase mediated signaling as the most represented
pathway.
Conclusions: rFgRab10 protein exerts profound influences on various functions of goat PBMCs. This finding may help
explain why F. gigantica is capable of provoking recognition by host immune cells, less capable of destroying this
successful parasite.
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Background
Fasciola gigantica and Fasciola hepatica are omnipresent
agents of a zoonotic parasitic disease, fascioliasis, which
continues to be a major health burden on animals and
humans. Fascioliasis can adversely affect the sustainabil-
ity of the farm animal industry [1]. The annual global
economic loss due to fascioliasis has been estimated to
be in excess of three billion dollars [2]. Worldwide, at
least 2.4 million people have been infected with fasciolia-
sis, with a further 180 million people at risk of being in-
fected [3]. Despite this high impact and investigations
for decades using clinical studies as well as animal
models, knowledge about host defense mechanisms
against F. gigantica is limited. This challenge is partly
due to the fact that Fasciola spp. are very efficient mod-
ulators of the host immune response [4]. The immuno-
modulatory capacity of F. gigantica, mediated by
parasite-derived effector molecules, is believed to play
important roles in the establishment of long-lasting in-
fection in the host.
Several studies have investigated various excretory/
secretory products (ESPs) and virulence effector mole-
cules employed by F. gigantica flukes to ensure their sur-
vival and establishment of persistent infection [5, 6]. Rab
proteins are a family of small GTP-binding proteins, part
of the Ras superfamily, which regulate intracellular
membrane trafficking of several pathogens; including
parasites (e.g. Plasmodium, Theileria, Cryptosporidium
and Babesia [7] and Toxoplasma gondii [8]), bacteria
(e.g. Mycobacterium spp. [9] and Listeria monocytogenes
[10]) and fungi [11]. Despite their crucial role as regula-
tors of vesicular membrane traffic, the roles of Rab pro-
teins in the pathogenesis of F. gigantica infection remain
largely unknown. Understanding the influence of
parasite-secreted proteins on the function of immune
cells, such as goat peripheral blood mononuclear cells
(PBMCs), is essential due to their important role in the
immunopathogenesis of fascioliasis [12]. In a recent
study, we cloned and expressed a recombinant F. gigan-
tica 14-3-3 epsilon protein (rFg14-3-3e), and character-
ized its effects on specific functions of goat PBMCs [6].
In the present study, we expand our investigation of
the effects of F. gigantica ESPs on the functions of these
immune cells. Specifically, the gene encoding F. gigan-
tica Rab10 (FgRab10) was cloned and expressed in
Escherichia coli. Then, the modulatory effects of the
purified recombinant FgRab10 (rFgRab10) protein on
the functions of goat PBMCs; including cytokine secre-
tion, proliferation, migration, nitric oxide (NO) produc-
tion, phagocytosis and apoptosis were investigated. Our
results indicate that rFgRab10 protein can significantly
influence key functions of goat PBMCs, all are critical
facets of the immunopathogenesis of F. gigantica
infection.
Methods
Animals
Three crossbred goats (3–6 months-old) were obtained
from the teaching and research flock at Nanjing Agricul-
tural University. Goats were treated with triclabendazole
(50 mg/kg body weight) in order to exclude the possibil-
ity of any prior infection with liver flukes. Two weeks
post-treatment, a faecal specimen from each goat was
examined microscopically to exclude the presence of
helminth eggs. Female Sprague Dawley (SD) rats
(150–200 g) were purchased from the Experimental Ani-
mal Center of Jiangsu Province, China (Certificate:
SCXK 2008-0004), and used for the production of anti-
bodies. Rats were raised under specific pathogen-free
conditions, and fed with sterilized food and water ad
libitum. All efforts were made to minimize the suffering
of animals, and daily health checks were performed
throughout the experiment.
Purification and culture of goat PBMCs
Venous blood samples were collected from the jugular
vein of goats, with no history of F. gigantica infection or
other parasitic infections, into Vacutainer tubes coated
with ethylenediaminetetraacetic acid (EDTA). PBMCs
were isolated from freshly collected blood using a PBMC
isolation kit (TBD, Tianjin, China). Culturing was done by
incubating the isolated PBMCs in RPMI 1640 medium
containing 10% fetal bovine serum (FBS) and 1%
penicillin-streptomycin (Gibco, New York, USA). Cultures
were maintained in a humidified atmosphere of 5% CO2
at 37 °C. The number of PBMCs was adjusted to 106 cells/
ml in RPMI 1640 medium and cell viability was assessed
using trypan blue dye exclusion method. The number of
viable cells was counted in a haemocytometer and only
cells with > 95% viability were used in the experiments.
All assays were performed using freshly isolated PBMCs.
For the monocyte phagocytosis experiment, adherent
monocytes were obtained after incubation of PBMCs for
48 h at 37 °C in 5% CO2, followed by removal of the
non-adherent cells. In all assays performed to investigate
the effects of rFgRab10 protein on certain functions of
goat PBMCs and monocytes, cultured cells were exposed
to rFgRab10 protein at concentrations of 10 μg/ml, 20 μg/
ml, 40 μg/ml or 80 μg/ml. PBMCs treated with SUMO
protein expressed in pET-SUMO expression vector and
sham-treated with phosphate buffered saline (PBS, pH
7.4) were used as controls in all assays. All experiments
were performed in triplicate.
Parasite strain
Adult F. gigantica flukes were harvested from the
gall-bladder of naturally infected buffaloes at local abat-
toirs in Guangxi Zhuang Autonomous Region, PR
China. The collected flukes were washed twice in PBS
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and used for RNA isolation or stored frozen at -80 °C with
RNA stabilizer for later analysis. The identity of the flukes
collected was ascertained to be F. gigantica based on PCR
and sequencing analysis of the second internal transcribed
spacer (ITS2) of ribosomal DNA [13]. This analysis re-
vealed 100% ITS2 sequence homology between the flukes
collected and F. gigantica samples examined previously
from the same region (GenBank: AJ557569).
Cloning and characterization of FgRab10 gene
Because F. gigantica genome sequences are not available,
we searched the NCBI/BLASTx (https://blast.ncbi.nlm.
nih.gov/Blast.cgi), F. hepatica cDNA library and liquid
chromatography-tandem mass spectrometry (LC-MS/
MS)-based F. hepatica ESPs dataset from previously un-
published proteomics studies to identify homologous Ras
family protein gene sequences. This analysis identified F.
hepatica Ras family protein gene (GenBank: PIS87503.1),
which was utilized to design primers to amplify F. gigan-
tica Ras-related protein Rab10 (FgRab10) gene. Total
RNA was isolated from adult F. gigantica flukes using Tri-
zol reagent (Invitrogen, San Diego, USA), and was used to
synthesize first-strand cDNA with reverse transcription
polymerase chain reaction (RT-PCR) using the RevertAid
First Strand cDNA Synthesis Kit [Thermo Scientific (EU),
Vilnius, Lithuania]. The cDNA was used for the amplifica-
tion of FgRab10 gene using a forward primer (5'-CCG
GAA TTC ATG GCT AAG AAG TCG TAC GAT G -3')
and a reverse primer (5'-ATT TGC GGC CGC TGTAGG
ACA CCA GGA GCA-3'). EcoR I and Not I restriction
sites, which were underlined, were incorporated into the
primers. The amplified FgRab10 gene was digested with
EcoR I and Not I, and ligated into the corresponding clon-
ing sites in the T-vector pMD19 (Simple) (Takara, Dalian,
Liaoning, China). The recombinant plasmid was trans-
formed into Trans5α chemically competent cells
(TransGen Biotech, Beijing, China). Positive clones
were sequenced by GenScript (Nanjing, Jiangsu, China)
in order to confirm the correct insertion/orientation of
FgRab10 gene in the vector. The FgRab10 cDNA se-
quence was translated into amino acid sequences using
EditSeq (DNASTAR Lasergene). The signal peptide and
conserved domains of FgRab10 were predicted by
SignalP 4.1 Server (http://www.cbs.dtu.dk/services/SignalP/),
and (https://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi),
respectively.
Expression and purification of rFgRab10 protein
Positive clones containing the FgRab10 gene were selected.
The FgRab10 gene fragment was sub-cloned into the
pET-SUMO expression vector. The pET-SUMO-FgRab10
plasmid was transformed into E. coli BL2 (DE3), then in-
duced by addition of 1 mM isopropyl-β-d-thiogalactopyran-
oside (IPTG) (Solarbio, Beijing, China) to a culture with an
optical density at 600 nm (OD600) of 0.6 at 37 °C. After 5
h, the bacterial cells were collected by centrifugation
(10,000× g, 10 min, 4 °C), resuspended in 5 ml imidazole
buffer (20 mM phosphate, 0.5 M NaCl, 10 mM imidazole),
and frozen at -20 °C. The cell preparation was sonicated at
600 W for 20 min and further centrifuged at 10,000× g for
10 min at 4 °C, and the recombinant His-tagged protein
was isolated from bacterial pellets under denaturing con-
ditions in a solution containing 8 M urea. After a third
centrifugation, the supernatant was purified using the His
GaviTrap kit (GE Healthcare, Buckinghamshire, UK). The
eluted protein was first dialyzed in a solution containing
0.1 M urea to be refolded and renatured in a buffer con-
taining a linear decreased urea gradient (6 M, 4 M, 2 M
and 0 M urea), and then dialyzed against PBS to remove
imidazole. The non-recombinant pET-SUMO expression
vector (without FgRab10 gene) was used to produce the
control His-tagged SUMO protein, which was expressed
and purified using the same method used to obtain
rFgRab10 protein. The lipopolysaccharide (LPS) was de-
pleted from the rFgRab10 protein using Detoxi-Gel Affin-
ity Pak prepacked columns (Thermo Scientific, Waltham,
MA, USA). The concentration of the rFgRab10 protein
was adjusted to 1 mg/ml. The endotoxin level of the sam-
ple was measured with a Limulus Amebocyte Lysate
(LAL) gel clot assay using a Pyrosate® Kit (Cape Cod Inc.,
East Falmouth, MA, USA).
Preparation of polyclonal antibodies
Polyclonal antibodies were produced by subcutaneous
immunization of SD rats with purified rFgRab10 protein.
Briefly, SD rats were immunized with 300 μg of the puri-
fied protein emulsified with complete Freund’s adjuvant
(1:1). After each 2-week interval, SD rats were boosted
four times with the same dose of the rFgRab10 protein
mixed with incomplete Freund’s adjuvant. One week
after the last injection, rat serum was collected and
stored frozen at -80 °C.
Western blot analysis of rFgRab10 protein
The purity of the protein was detected by 12%
SDS-PAGE, followed by Coomassie blue staining. Also, 20
μg of the purified rFgRab10 protein were resolved on 12%
SDS-PAGE and transferred onto Hybond-C extra nitrocel-
lulose membrane (Amersham, London, UK). The mem-
brane was washed 5 times (5 min each) in TBS-T. The
membrane was then incubated with primary antibodies
(serum from sheep naturally infected with Fasciola) for 1
h at 37 °C (1:100 in TBS-T). After washing 5 times in
TBS-T, the membrane was incubated with horseradish
peroxidase (HRP)-conjugated rabbit anti-goat immuno-
globulin (Ig)-G antibody (Sigma, St. Louis, MO, USA) at
37 °C for 1 h (1:2000 in TBS-T). The immunoreaction was
visualized using WesternBright ECL (Advansta, Menlo
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Park, CA, USA) and LucentBlue X-ray film (Advansta,
Menlo Park, CA, USA).
Immunofluorescence staining of rFgRab10 protein bound
to goat PBMCs
PBMCs were incubated with rFgRab10 protein in a humidi-
fied atmosphere of 5% CO2 at 37 °C for 1 h. Cells were
fixed with 4% paraformaldehyde, washed 3 times in PBS
and treated with blocking solution (4% BSA in PBS) for 1 h
to minimize background staining. rFgRab10-treated,
SUMO protein-treated, or PBS-treated PBMCs were
incubated with rat anti-rFgRab10 protein antibody (1:100 in
4% BSA) for 1 h at 37 °C. Cells were stained with Cy3
conjugated goat anti-rat IgG secondary antibody (1:500 in
4% BSA) (Beyotime, Jiangsu, China) for 1 h at 37 °C.
Hoechst 33342 (Invitrogen, Oregon, USA) was used to
stain the nuclei. Stained cells were imaged using a confocal
laser scanning microscope (LSM710, Zeiss, Jena, Germany)
and digital images were analyzed using Zen 2012 imaging
software.
Quantification of cytokines in goat PBMCs culture
supernatant
Cytokine production was detected in the culture superna-
tants of PBMCs incubated with rFgRab10 protein. PBMCs
were plated at a cell density of 106 cells/well in 24-well tis-
sue culture plates in 1 ml culture medium with various
concentrations (10, 20, 40 and 80 μg/ml) of rFgRab10
protein. The culture plates were maintained in 5% CO2 at
37 °C for 24 h. The PBMCs supernatant was then collected
and assayed for the production of interleukin (IL)-2, IL-4,
IL-10, transforming growth factor beta (TGF-β) and inter-
feron gamma (IFN-γ) using goat ELISA kit (Mlbio,
Shanghai, China). Limits of detection were between 2 and
1200 pg/ml depending on the cytokine.
Assessment of nitric oxide (NO) production
PBMCs were seeded into 24-well flat-bottomed plates at
106 cells per well in 1 ml RPMI medium. PBMCs were
allowed to adhere for 2 h in 5% CO2 at 37 °C; cells were
then stimulated by rFgRab10 protein using the same con-
centrations used above. The supernatant was collected
after 24 h and analyzed for NO production by Total Nitric
Oxide Assay Kit (Beyotime, Haimen, Jiangsu, China). A
microplate reader (Bio-Rad, Hercules, CA, USA) was used
to measure the optical density at 540 nm (OD540). NO
levels were calculated against a standard curve generated
using 0-80 μM/l sodium nitrites.
Determination of apoptosis assay using Annexin V/PI staining
PBMCs were seeded into 24-well tissue culture plates at
106 cells/well in 1 ml RPMI medium with each of the
rFgRab10 protein concentrations used above. The plate
was incubated in 5% CO2 at 37 °C for 24 h. PBMCs were
then stained with Annexin V and PI using the Annexin
V-FITC kit (Miltenyi Biotec, Bergisch Gladbach,
Nordrhein-Westfalen, Germany). Apoptosis in PBMCs
was quantified by flow cytometry. Data were analyzed
using FlowJo 10. Annexin V-positive/PI-negative PBMCs
were considered to be apoptotic and were analyzed as a
percentage of the entire PBMCs population.
In vitro goat PBMCs migration assay
To test whether rFgRab10 protein can stimulate the in
vitro the migration of PBMCs, we assessed the move-
ment of untreated and rFgRab10-tretaed PBMCs from
the upper chamber of a Transwell plate (Corning, Ken-
nebunk, USA), through an 8-μm-pore polycarbonate
membrane inserts toward the lower chamber. Briefly,
~106 cells in 100 μl RPMI medium without or with
rFgRab10 at the concentrations used above were seeded
into the upper chamber of the Transwell in 24-well tis-
sue culture plates. The bottom chamber was filled with
~600 μl RPMI medium. The plate was incubated in 5%
CO2 at 37 °C for 4 h. After incubation, PBMCs were col-
lected from the bottom chamber and the number of cells
migrated through the membrane into the lower chamber
was determined using an Automated Cell Counter
(Countstar, Shanghai, China). The results are presented
as percentages of the seeded PBMCs.
Measurement of FITC-dextran uptake
Goat monocytes were seeded into 24-well tissue culture
plates at 106 cells/well in 1 ml RPMI medium with the
various rFgRab10 protein concentrations. The plate was
incubated in 5% CO2 at 37 °C for 48 h. After centrifuga-
tion at 500× g, monocytes were resuspended in chilled
PBS, and incubated with 1 mg/ml FITC-dextran (average
molecular weight of dextran, 4000; Sigma, St. Louis,
MO, USA) in RPMI 1640 Medium at 4 °C or 37 °C for 1
h in darkness. To halt phagocytosis, chilled PBS contain-
ing 2% FBS was added after incubation and goat mono-
cytes were washed trice with PBS and resuspended in
chilled PBS. FITC-dextran uptake of monocytes was ana-
lyzed using flow cytometry (BD Biosciences, San Jose,
CA, USA). The data were analyzed using FlowJo 10.
Determination of goat PBMCs proliferation
PBMCs were plated in 96-well tissue culture plates at a
cell density of 104 PBMCs/well in triplicate in 100 μl
complete RPMI medium with each of the rFgRab10 pro-
tein concentrations used above. The plate was incubated
in a humidified atmosphere of 5% CO2 at 37 °C. After
48 h, 10 μl of Cell Counting Kit-8 (CCK-8) (Beyotime,
Jiangsu, China) reagent was added to each well and the
plate was further incubated under the same conditions
in darkness. A microplate reader (Bio-Rad) was used to
measure the optical density at 450 nm (OD450).
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Bioinformatics
We used blastx (https://blast.ncbi.nlm.nih.gov/) to ob-
tain the protein sequence of rFgRab10 and the Frag-
ments Library of ROBETTA (http://robetta.bakerlab.org/
) [14] to obtain the 3-mer and 9-mer fragments. Using
the sequence of rFgRab10, and the 3-mers and 9-mers,
the de novo 3D protein structure was predicted using
ROSETTA’s AbinitioRelax function (https://www.rosetta
commons.org/) [15]. The pdb result was aligned to the
human Rab10 chain A protein using the Match-maker
and match-align tools of UCSF Chimera (https://
www.cgl.ucsf.edu/chimera/) [16]. UCSF Chimera was
also used to visualize the ab initio structure and the
alignment to the human Rab10 chain A protein.
Protein Blast [17] was used to retrieve the protein se-
quence of humans (taxid: 9606), most similar to the
rFgRab10 protein sequence. The human Rab10 protein
(Uniprot ID: P61026) was used to query interactions in
the following databases: Intact [18], String [19], BioPlex
[20] and BioGrid [21]. The results were summarized and
filtered by P61026 (Rab10) protein using a Python script;
this list of interacting pairs was the input used to obtain
structure interactions using Interactome3D [22]. All ex-
perimental and modeled interactions were used to build
a model using the aligned fasta recombinant Rab10 pro-
tein sequence to the P61026 (Rab10) protein. A total en-
ergy analysis was performed using FoldX Suite [23] in
order to calculate the structure energy of each protein
involved in the interaction. We used Cytoscape (http://
www.cytoscape.org/) to build a protein interaction net-
work. Finally, Gene Ontology (GO) enrichment analysis
was performed, using as input the 13 human proteins
that interacted with P61026 (Rab10), using FuncAssoci-
ate 3.0 [24].
Statistical analysis
Data values were expressed as the mean ± standard devi-
ation (SD). Differences between the groups were examined
for statistical significance using GraphPad Prism 6.0. Stat-
istical analysis was performed using one-way analysis of
variance (ANOVA). P values < 0.05, 0.01, 0.001 and
0.0001 were represented as *, **, *** and ****, respectively,
in comparison with untreated controls. All experiments
were repeated at least three independent times.
Results
Cloning of FgRab10 gene
PCR products (~618 bp) of FgRab10 gene were success-
fully cloned into T-vector pMD19. The identity of the
construct (pMD19T-FgRab10) was verified by DNA se-
quence analysis. FgRab10 is a 205 amino-acid protein with
a molecular mass of ~23 kDa (GenBank: MH532439).
Conserved domain analysis showed that FgRab10 protein
belonged to P-loop NTPase domain superfamily. Amino
Fig. 1 SDS-PAGE and Western blot analyses of the purified rFgRab10 protein from the sonicated culture sediment of E. coli. a rFgRab10 protein
was resolved on 12% acrylamide gel and stained with Coomassie blue. Lane M: prestained protein ladder in kilodaltons; Lane P: purified recombinant
protein, rFgRab10, which appeared as a single band of ~39 kDa. b rFgRab10 protein was run under non-reducing conditions, and the immunoreaction
was visualized using chemiluminescent HRP substrate and X-ray film. Lane M: prestained protein ladder; Lane P: loaded with rFgRab10 protein expressed
from E. coli. Serum from Fasciola-infected sheep detected a single band of ~39 kDa; Lane C1: loaded with protein expressed from sonicated culture
supernatant of E. coli transformed with empty pET-SUMO vector without rFgRab10 gene insert, which did not react with goat serum containing anti-F.
gigantica IgG antibodies; Lane C2: loaded with rFgRab-10 protein expressed from E. coli that did not react with the serum of healthy uninfected goats
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acid sequence comparison of the FgRab10 gene with that
of F. hepatica Ras family protein gene (GenBank:
PIS87503.1) showed 100% sequence homology.
SDS-PAGE and Western blot analysis
The FgRab10 gene fragment was successfully sub-cloned
into pET-SUMO expression vector and the positive clones,
pET-SUMO-FgRab10, were induced by IPTG in E. coli
BL2 (DE3). The recombinant rFgRab10 protein was success-
fully expressed as a soluble His-tagged fusion protein using
the small ubiquitin-like modifier (SUMO). A protein with
an apparent molecular mass of ~39 kDa (~23 kDa rFgRab10
protein + ~16 kDa SUMO tag protein) was detected in
SDS-PAGE (Fig. 1a). The specificity of rFgRab10 protein
was confirmed by Western blot analysis, wherein rFgRab10
protein specifically reacted with serum from Fasciola-in-
fected sheep as indicated by the presence of a single ~39
kDa band. No bands were observed in negative controls
[empty pET-SUMO vector without rFgRab10 gene insert or
in samples probed with serum from healthy sheep (Fig. 1b)].
Binding affinity of rFgRab10 protein to goat PBMCs
Binding of rFgRab10 protein to PBMCs surface was deter-
mined by immunofluorescent staining. By incubating
rFgRab10-treated PBMCs with specific anti-rFgRab10
antibodies, we detected an even distribution and
localization of the red Cy3 dye on the PBMCs membrane,
indicating the successful binding of rFgRab10 protein to
PBMCs surface (Fig. 2). No fluorescence was observed in
PBMCs incubated with SUMO protein obtained from
sonicated culture supernatant of E. coli transformed with
empty pET-SUMO vector or in PBS-treated goat PBMCs.
rFgRab10 protein modulates cytokine production by goat
PBMCs
rFgRab10 protein caused alteration in the levels of five cy-
tokines, IL-2, IL-4, IL-10, IFN-γ and TGF-β. As shown in
Fig. 3, when PBMCs were treated with different concen-
trations of rFgRab10 protein, the production of cytokines
was significantly increased, when compared with PBMCs
treated with SUMO protein obtained from sonicated cul-
ture of E. coli transformed with empty pET-SUMO vector
(ANOVA tests: IL-2 (0 μg/ml: F(5, 48) = 53.63, P = 0.0778; 10
μg/ml: F(5, 48) = 53.63, P < 0.0001; 20 μg/ml: F(5, 48) =
53.63, P < 0.0001; 40 μg/ml: F(5, 48) = 53.63, P < 0.0001; 80
μg/ml: F(5, 48) = 53.63, P < 0.0001), IL-4 (0 μg/ml: F(5, 48) =
47.06, P = 0.8419; 10 μg/ml: F(5, 48) = 47.06, P = 0.0020; 20
μg/ml: F(5, 48) = 47.06, P < 0.0001; 40 μg/ml: F(5, 48) =
Fig. 2 Localization of F. gigantica-derived rFgRab10 protein to the PBMCs surface. rFgRab10 protein binding to goat PBMCs surface was determined
by incubating PBMCs treated with purified rFgRab10 protein, protein from sonicated culture of E. coli transformed with empty pET-SUMO vector or
sham-treated with PBS (control) with primary anti-rFgRab-10 protein antibody raised in rats. PBMCs’ nuclei and rFgRab10 protein were stained by
Hoechst 33342 (blue) and Cy3-conjugated secondary antibody (red), respectively. Surface staining was detected in rFgRab10-treated cells, but not in
PBMCs incubated with SUMO protein and sham-treated PBMCs. Scale-bars: 10 μm
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47.06, P < 0.0001; 80 μg/ml: F(5, 48) = 47.06, P < 0.0001),
IL-10 (0 μg/ml: F(5, 48) = 39.92, P = 0.9661; 10 μg/ml: F(5, 48)
= 39.92, P < 0.0001; 20 μg/ml: F(5, 48) = 39.92, P < 0.0001; 40
μg/ml: F(5, 48) = 39.92, P < 0.0001; 80 μg/ml: F(5, 48) =
39.92, P < 0.0001), TGF-β (0 μg/ml: F(5, 48) = 83.54, P =
0.0839; 10 μg/ml: F(5, 48) = 83.54, P < 0.0001; 20 μg/ml: F(5, 48)
= 83.54, P < 0.0001; 40 μg/ml: F(5, 48) = 83.54, P < 0.0001;
80 μg/ml: F(5, 48) = 83.54, P < 0.0001), and IFN-γ (0 μg/ml:
F(5, 48) = 83.54, P = 0.0839; 10 μg/ml: F(5, 48) = 83.54,
P < 0.0001; 20 μg/ml: F(5, 48) = 83.54, P < 0.0001; 40
μg/ml: F(5, 48) = 83.54, P < 0.0001; 80 μg/ml: F(5, 48)
= 83.54, P < 0.0001).
rFgRab10 protein promotes goat PBMCs NO production
As shown in Fig. 4, NO release from PBMCs was signifi-
cantly increased in the presence of rFgRab10 protein
compared with controls, but not at 0 μg/ml and 10 μg/
ml (ANOVA tests: 0 μg/ml: F(5, 24) = 126.2, P = 0.2183;
10 μg/ml: F(5, 24) = 126.2, P = 0.9998; 20 μg/ml: F(5, 24) =
126.2, P < 0.0001; 40 μg/ml: F(5, 24) = 126.2, P < 0.0001;
80 μg/ml: F(5, 24) = 126.2, P < 0.0001).
rFgRab10 protein stimulates goat PBMCs apoptosis
We monitored the level of apoptosis in rFgRab10-treated
PBMCs using the Annexin V-FITC/PI double staining
Fig. 3 rFgRab10 protein induced the cytokine secretion. Goat PBMCs were incubated for 24 h in the presence of serial concentrations of
rFgRab10 protein. PBMCs incubated with SUMO protein or PBS-treated PBMCs served as controls. The levels of cytokine concentration in the
supernatant of cultured PBMCs was quantified by ELISA. Graphs represent means ± SD of data from three independent biological replicates.
Asterisks indicate statistical significance between the different indicated groups (**P < 0.01; ****P < 0.0001; ns, non-significant)
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apoptosis assay. rFgRab10 protein significantly induced
apoptosis in PBMCs in a dose-dependent manner
(ANOVA tests: 0 μg/ml: F(5, 48) = 117.6, P = 0.5249;
10 μg/ml: F(5, 48) = 117.6, P = 0.7685; 20 μg/ml: F(5, 48) =
117.6, P = 0.0531; 40 μg/ml: F(5, 48) = 117.6, P < 0.0001; 80
μg/ml: F(5, 48) = 117.6, P < 0.0001) (Fig. 5).
rFgRab10 protein stimulates goat PBMCs migration
rFg14-3-3e protein significantly promoted, in a dose-
dependent manner, the migration of goat PBMCs at all
tested concentrations compared to control PBMCs treated
with SUMO protein (10 μg/ml: F(5, 12) = 176.5, P = 0.0230;
20 μg/ml: F(5, 12) = 176.5, P = 0.0015; 40 μg/ml: F(5, 12) =
176.5, P < 0.0001; 80 μg/ml: F(5, 12) = 176.5, P < 0.0001;
one-way ANOVA) (Fig. 6).
rFgRab10 protein increases goat monocyte phagocytosis
We determined whether rFgRab10 protein influences
the phagocytic ability of monocytes that were cultured
with PBS, SUMO protein or serial concentrations of
rFgRab10 protein prior to exposure to FITC-dextran.
The phagocytic capability of monocytes was examined
by assessment of FITC-dextran uptake. rFgRab10 protein
at 10 μg/ml, 20 μg/ml and 40 μg/ml (but not at 80 μg/ml)
significantly increased the phagocytic ability of monocytes
compared with cells incubated with SUMO protein (10
μg/ml: F(5, 48) = 28.37, P = 0.0006; 20 μg/ml: F(5, 48) =
28.37, P < 0.0001; 40 μg/ml: F(5, 48) = 28.37, P < 0.0001;
F(5, 48) = F7 495 28.37, P = 0.4258; oneway ANOVA)
(Fig. 7).
rFgRab10 protein inhibits goat PBMCs proliferation
rFgRab10 protein at 20 μg/ml, 40 μg/ml and 80 μg/ml
concentrations (but not at 10 μg/ml) significantly inhib-
ited PBMCs proliferation compared with PBMCs treated
with SUMO protein obtained from E. coli transformed
with empty pET-SUMO vector (10 μg/ml: F(5, 30) =
140.5, P = 0.5720; 20 μg/ml: F(5, 30) = 140.5, P < 0.0001;
40 μg/ml: F(5, 30) = 140.5, P < 0.0001; 80 μg/ml: F(5, 30) =
140.5, P < 0.0001; one-way ANOVA) (Fig. 8).
3D modeling
The Protein Blast result showed that the rFgRab10 protein
was very similar to Chain A, structure of Human Rab10,
with an identity of 63%, an E-value of 3e-85, a Query
cover of 90% and a Max score of 253. The human Rab10
protein is a 200 amino-acid protein, with a molecular
mass of ~22.5 KDa and is annotated as Ras-related protein
Rab10 (Uniprot ID: P61026). De novo rFgRab10 protein
structure (Fig. 9) was similar to human Rab10 protein.
Figure 10 shows the structure alignment of rFgRab10 pro-
tein to the human Rab10 protein, and Fig. 11 shows a 3D
representation of both proteins at the same time: Chain A
of Rab10 human protein (red) and rFgRab10 protein
(blue), with the aligned region shown in yellow.
Protein interactions analysis
Interactome3D analysis detected 36 interactions between
human Rab10 (P61026) and 13 other human proteins. All
interactions with their respective total energy for the
WildType (P61026 - human Rab10), Total Energy Mutant
(rFgRab10 protein sequence aligned to P61026), and the
difference of the previous values are provided in Add-
itional file 1: Table S1. The protein interactions network
(Fig. 12) showed that Rab proteins geranylgeranyltransfer-
ase component A 1 (CHM) and Rab proteins geranylgera-
nyltransferase component A 2 (CHML) had more stable
interactions (red edges) with rFgRab10 protein compared
to the human ortholog, whereas [F-actin]-monooxygenase
MICAL3 (MICAL3) and guanine nucleotide exchange
factor MSS4 (RABIF) had fewer stable interactions (blue
edges) with rFgRab10 protein. These interacting partners were
enriched in terms related to RabGTPase signalling, with Rab
GDP-dissociation inhibitor activity (GO:0005093), Rab-protein
geranylgeranyltransferase complex (GO:0005968) and protein
geranylgeranylation (GO:0018344), being the overrepresented
GO terms (Additional file 2: Table S2).
Discussion
To establish a persistent infection in their mammalian
definitive host, liver flukes have developed sophisticated
strategies to interfere with the host’s immune response.
In a recent study, we showed that rFg14-3-3e protein,
another F. gigantica ESP, modulates several cellular and
immunological functions of goat PBMCs [6]. In the
Fig. 4 Effects of rFgRab10 protein on the production of intracellular
NO. PBMCs were sham-treated with PBS, SUMO protein or serial
concentrations of rFgRab10 protein and incubated for 24 h at 37 °C
at 5% CO2. NO concentration in the PBMCs was measured using
Griess assay. Graphs represent means ± SD of data from 3 independent
biological replicates. Asterisks indicate statistical significance between the
different indicated groups (****P < 0.0001; ns, non-significant)
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present study, the gene encoding Rab10 of F. gigantica
was amplified by PCR, cloned, and expressed in a pro-
karyotic expression system. SDS-PAGE and Western
blot analysis of the recombinant protein (rFgRab10)
using sera from Fasciola-infected sheep revealed a mo-
lecular mass of ~23 kDa. rFgRab10 protein cross-reacted
with anti-rFgRab10 antibody as indicated by specific
binding of rFgRab10 protein to the surface of the
PBMCs. Thus, it is reasonable to hypothesize that stimu-
lation of goat PBMCs with rFgRab10 protein may
interfere with several functions of PBMCs. Understand-
ing the mechanisms of rFgRab10 interaction with
PBMCs has important in vivo relevance for the defin-
ition of early events of the cellular responses to
rFgRab10 released by liver flukes during infection.
Therefore, we examined the influences of rFgRab10 pro-
tein on various functions of goat PBMCs. When incu-
bated with PBMCs, rFgRab10 protein significantly (i)
promoted the secretion of IL-2, IL-4, IL-10, TGF-β, and
IFN-γ; (ii) increased the release of total NO from
Fig. 5 rFgRab10 protein induced apoptosis in PBMCs. Annexin V/PI staining combined with flow cytometry analysis was used to count apoptotic
cells. a Dot plots showing apoptosis of PBMCs in response to exposure to rFgRab10 protein. b Percentage of cell population was compared with
plotted apoptotic cells (Annexin V+/PI-). Graphs represent means ± SD of data from three independent biological replicates. Asterisks indicate
statistical significance between rFgRab10-treated, SUMO protein and sham-treated PBMCs (****P < 0.0001; ns, non-significant). The statistical
significance was only achieved at the two highest concentrations (40 μg/ml and 80 μg/ml)
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PBMCs; (iii) stimulated goat PBMCs apoptosis and mi-
gration; and (iv) enhanced monocyte phagocytosis; but
(v) inhibited PBMCs proliferation. Alterations of these
functions in PBMCs may contribute to multiple aspects
of F. gigantica pathogenesis.
Cytokines are produced by a variety of leukocytes and
play many roles in maintaining immune homeostasis in
the host [25, 26]. Fasciola gigantica infection can induce
a mixed Th1/Th2 immune response [27, 28]. Our evalu-
ation of the cytokine production [Th1 (IFN-γ and IL-2)
and Th2 (IL-4, IL-10 and TGF-β)] in PBMCs culture su-
pernatants showed that rFgRab10 protein can induce
both humoral and cellular immune responses, confirm-
ing an earlier observation [27, 28]. Th1 cells secrete
Fig. 6 rFgRab10 protein promoted goat PBMCs migration. PBMCs
were treated with PBS, SUMO protein or serial concentrations of
rFgRab10 protein and then the goat PBMCs migration percentage
(%) was determined. Graphs represent means ± SD of data from 3
independent biological replicates. Asterisks indicate statistical significance
between the different indicated groups (*P < 0.05; **P < 0.01;
****P < 0.0001; ns, non-significant)
Fig. 7 rFgRab10 protein promoted phagocytosis of goat monocytes.
rFgRab10 protein increased the phagocytic ability of goat monocytes
as indicated by the increase in FITC-dextran uptake in goat
monocytes treated with serial concentrations of rFgRab10
protein, compared with those treated with PBS or SUMO protein.
Graphs represent means ± SD of data from three independent
biological replicates. Asterisks indicate statistical significance between
the different indicated groups (***P < 0.001; ****P < 0.0001;
ns, non-significant)
Fig. 8 rFgRab10 protein inhibited goat PBMCs proliferation. Goat
PBMCs were treated with PBS, SUMO protein or serial concentrations
of rFgRab10 protein and incubated for 48 h at 37 °C at 5% CO2.
Proliferation of goat PBMCs was determined using CCK-8 assay.
Results indicated that rFgRab10 protein significantly inhibited PBMCs
proliferation. Mean values and the respective standard deviation of three
independent experiments are presented. Asterisks indicate statistical
significance between the different indicated groups (****P <
0.0001; ns, non-significant)
Fig. 9 De novo 3D ab initio model for rFgRab10 protein. The model
was generated using Rosetta
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IFN-γ, which activates monocytes, thereby promoting the
production of NO and phagocytosis [29], which may influ-
ence the development of the adaptive cellular immune re-
sponse. Th2 cells secrete IL-4 to mediate humoral
immunity and control helminthic infection [30] via the
production of IgE by B cells, which can activate
antibody-dependent killing of eosinophils, macrophages
and mast cells [31–33]. Earlier studies indicated that apop-
totic cells may participate in suppressing inflammatory re-
sponses through inducing the anti-inflammatory cytokines
IL-10 [34, 35] and TGF-β [36, 37], which inhibit T-cell acti-
vation and differentiation [38]. Thus, reduced proliferation
of rFgRab10-treated PBMCs is likely to be caused by cyto-
kines IL-10 and TGF-β, released from apoptotic PBMCs.
Induction of apoptosis to prevent potentially harmful
immune responses has been reported in macrophages and
eosinophils exposed to F. hepatica ESPs [39, 40]. The
same observation has been reported in peritoneal leuco-
cytes of sheep experimentally infected with F. hepatica,
and has been assumed to facilitate the juvenile flukes sur-
vival during the migration through the peritoneum to the
liver [41]. Fasciola hepatica seemed to suppress the in-
flammatory response by inducing apoptosis in goat
PBMCs [42]. Likewise, F. gigantica rFg14-3-3e protein sig-
nificantly induced apoptosis in goat PBMCs [6]. In sup-
port of these findings, we have demonstrated the
induction of apoptosis in goat PBMCs cultures following
in vitro exposure to rFgRab10 protein. rFgRab10-mediated
reduction in cellular proliferation and increased apoptosis
of PBMCs seems to be mechanisms employed by F. gigan-
tica to evade host immune defenses.
A previous study indicated that the intrinsic mito-
chondrial pathway and the extrinsic death receptor
Fig. 10 The structure alignment of rFgRab10 to the human Rab10 protein. The predicted rFgRab10 model shared 63% similarity with the human
Rab10 protein (Uniprot ID: P61026)
Fig. 11 3D representation of both rFgRab10 protein and human
Rab10 protein: Chain A of human Rab10 protein (red) and rFgRab10
protein (blue), with the aligned region shown in yellow
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pathway may impact F. hepatica-induced apoptosis in
goat PBMCs [42]. However, apoptotic mechanisms may
vary in response to different parasite effectors and the
mechanism that underpins rFgRab10 protein-induced
apoptosis remains unknown. The host immune system
produces substances with oxidizing activities, such as
NO, reactive oxygen species (ROS) and reactive nitrogen
intermediates (RNI) in order to counter the parasite in-
fection [43, 44]. NO can be released by a variety of im-
mune cells, especially in response to IFN-γ stimulation
[29, 45]. Our data show that rFgRab10 protein promoted
the secretion of IFN-γ from PBMCs [46]. IFN-γ is a po-
tent inducer of nitric oxide synthase 2 (Nos2) in a range
of leukocytes, which converts l-arginine into l-citrulline
and NO [47]. NO may therefore serve as a mediator of
IFN-γ-induced cellular damage. Further studies are war-
ranted to investigate the process by which rFgRab10
protein induces apoptosis in goat PBMCs.
Our bioinformatics analysis revealed 63% identity be-
tween rFgRab10 and human Rab10 protein (Uniprot ID:
P61026). The diverse roles of rFgRab10 protein suggest
that this protein functions through coordinated interac-
tions with several regulatory partners. Thus, we used hu-
man Rab10 as an input to identify potential interactions
of rFgRab10 protein with human proteins in major
databases. Interactions identified between rFgRab10 and
human proteins were of special interest. The protein
interaction network revealed that Rab proteins geranyl-
geranyltransferase component A 1 (CHM) and Rab pro-
teins geranylgeranyltransferase component A 2 (CHML)
had more stable interactions with rFgRab10 protein,
whereas [F-actin]-monooxygenase MICAL3 (MICAL3)
and guanine nucleotide exchange factor MSS4 (RABIF)
had fewer stable interactions with rFgRab10 protein.
Host-parasite protein interactions are critical determi-
nants in pathogenesis. Our study provides the first iden-
tification of host protein partners for rFgRab10 protein.
Further understanding of the interactions existing be-
tween rFgRab10 and host proteins, and how the involved
proteins interact, can advance our understanding of mo-
lecular mechanisms involved in F. gigantica infection
and provide new opportunities for developing immuno-
modulatory therapies. We also performed GO enrich-
ment analysis, which identified terms related to
Rab GTPase signaling, with Rab GDP-dissociation in-
hibitor activity, Rab-protein geranylgeranyltransferase
complex, and protein geranylgeranylation. These find-
ings suggest that rFgRab10 can initiate signaling events
to modulate various cellular immune functions that may
have implications in F. gigantica pathogenesis.
Fig. 12 The protein interaction network revealed more stable interactions, compared to the human ortholog Rab10, between Rab proteins
geranylgeranyltransferase component A 1 (CHM) and Rab proteins geranylgeranyltransferase component A 2 (CHML) and rFgRab10 sequence
(red edges); whereas fewer stable interactions were detected between [F-actin]-monooxygenase MICAL3 (MICAL3) and Guanine nucleotide
exchange factor MSS4 (RABIF) proteins and rFgRab10 (blue edges)
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Conclusions
To our knowledge, this is the first study to characterize
the rFgRab10 protein and to illustrate that this protein,
when incubated with goat PBMCs, modulates the cellular
immune response, and enhances the release of NO, cell
apoptosis, cell migration, and monocyte phagocytosis, but
inhibits cell proliferation. The demonstration of the
cross-reactivity of rFgRab10 protein with serum from in-
fected animals, its binding to and interaction with goat
PBMCs, and its influence on various cellular functions
suggest that rFgRab10 protein plays various roles in the
immunopathogenesis of fascioliasis. The immunomodula-
tory roles of rFgRab10 protein and its potential to influ-
ence the host-parasite equilibrium in the context of F.
gigantica infection makes rFgRab10 a potentially good
candidate for developing an immunomodulatory therapy
for F. gigantica infection. Our study provided a “proof of
concept” for clinical evaluation of the immunomodulatory
roles of rFgRab10 protein in infected goats.
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